Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,General Medicine
Reference14 articles.
1. Al-Mansour Z, Nelson BP, Evens AM. Post-transplant lymphoproliferative disease (PTLD): risk factors, diagnosis, and current treatment strategies. Curr Hematol Malig Rep. 2013;8:173–83.
2. Green M, Michaels MG. Epstein-Barr virus infection and posttransplant lymphoproliferative disorder. Am J Transplant. 2013;13(Suppl 3):41–54 (quiz).
3. Patek B, Strahotin C. Early onset post-transplant lymphoproliferative disorder presenting with diarrhea post-orthotopic liver transplant treated successfully with single rituximab agent. Cureus. 2019;11: e6200.
4. Inayat F, Hassan GU, Tayyab GUN, et al. Post-transplantation lymphoproliferative disorder with gastrointestinal involvement. Ann Gastroenterol. 2018;31:248–51.
5. Younes BS, Ament ME, McDiarmid SV, et al. The involvement of the gastrointestinal tract in posttransplant lymphoproliferative disease in pediatric liver transplantation. J Pediatr Gastroenterol Nutr. 1999;28:380–5.